Covestor
CRMD icon

Covestor’s CorMedix CRMD Stock Holding History

Covestor’s Portfolio CRMD Stock Details CRMD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q3 		$8K Buy
+1,009
New +$8.08K 0.01% 1622

Other funds holding CRMD

BlackRock
BlackRock New York $6.79T AUM 37.06% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.76T AUM
American Century Companies
American Century Companies Kansas City, Missouri $229B AUM 33.35% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.44T AUM 36.12% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $765B AUM 28.39% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.92T AUM 36.1% 1-Year Est. Return
Royce & Associates
Royce & Associates New York $11B AUM 39.4% 1-Year Est. Return
Marshall Wace
Marshall Wace London, United Kingdom $114B AUM 35.47% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.21T AUM
Morgan Stanley
Morgan Stanley New York $1.96T AUM 27.49% 1-Year Est. Return

Covestor's CRMD Position: Q3 2026 in Review

Covestor opened a new position in CorMedix (CRMD) in Q3 2026: 1,009 shares worth $8K. The stake represents 0.01% of the portfolio and ranks #1622 among its holdings.

144 funds tracked by Wall St. Rank hold CRMD as of Q3 2026.

  • Covestor held 1,009 shares of CorMedix worth $8K as of Q3 2026.
  • CorMedix was a new Covestor position in Q3 2026.
  • CorMedix made up 0.01% of Covestor's portfolio in Q3 2026, its #1622 holding.
  • 144 funds tracked by Wall St. Rank held CorMedix as of Q3 2026.

Based on Covestor's 13F filing for Q3 2026, filed 30 Oct 2026.